Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million ...

RNA-3927 is a strong strategic fit with Recordati’s rare Metabolic portfolio Collaboration combines Moderna’s expertise in mRNA technology for rare metabolic disorders with Recordati’s established ...

Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer was recently asked about. Noting that the company is working on a ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million in upfront and near-term development and regulatory milestones, in addition to c ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

Vaults are mysterious cellular structures that can be genetically engineered to store information about a cell’s history.

Researchers from the National University of Singapore (NUS) have developed a "capping-and-coupling" strategy to transform ...

Officials have confirmed bird flu in a backyard flock in Ottawa County, marking Michigan’s first case of the year.

UTIs can be painful, and they’re not something people like to talk about. But they happen often, affecting an estimated 60% ...

About a month into the new year, exchange-traded funds (ETFs) are beginning to build up enough of a performance record for 2026 to potentially differentiate themselves from the broader market. The ...

1. Australian hiker stops in Montana during attempt to become first woman to walk length of the Americas ...